CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
118 hedge funds and large institutions have $755M invested in Cymabay Therapeutics in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+11
Holders Change %
+10.28%
% of All Funds
2.71%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
45
Increased
36
Reduced
28
Closed
34
Calls
$640K
Puts
$491K
Net Calls
+$149K
Net Calls Change
-$906K
Top Buyers
| 1 |
BlackRock
New York
|
+$38.7M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$27.7M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$19.4M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$17.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$42.5M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.4M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
-$8.31M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.15M |
| 5 |
Goldman Sachs
New York
|
-$5.13M |
